FDA
-
In an unusual turn of events a new Alzheimer’s drug, previously declared a failure in March, has been resurrected with the pharmaceutical company behind the treatment suggesting the earlier decision was premature and based on incorrect data analysis.
-
A new update on the ongoing vaping crisis has revealed nearly 1,500 lung injury cases have been identified, with 33 confirmed deaths. Alongside this news, Juul announced it is suspending sales of four popular e-cigarette flavors pending FDA review.
-
The first oral immunotherapy agent to treat peanut allergy is set to be approved, but questions still remain over how effective and long-lasting it is.
-
Amid the e-cigarette health crisis in the US, the Trump administration announced a plan to ban all non-tobacco-flavored e-cigarette products.
-
A cold atmospheric plasma system designed to prevent cancer relapse has been approved for human clinical trials by the FDA.
-
The FDA is again warning the public to avoid consuming a product called Miracle Mineral Solution (MMS). Despite over a decade of health warnings and cases of death, the sham product, which is essentially bleach, is still being consumed as a miracle cure for everything from autism to cancer and HIV.
-
A newly published statement from the US Food & Drug Administration (FDA) has revealed inaccurate, intentionally manipulated data was included as part of a submission for a major new gene therapy that was approved for public use in May.
-
The Wisconsin Department of Health Services is reporting a number of hospitalizations of teenagers displaying severe lung disease, with suspicions of links to e-cigarette use. The FDA has also recently revealed it has accumulated 127 reports of seizures claimed to be related to e-cigarette use.
-
ScienceImpossible Foods’ plant-based meat alternative will finally be hitting grocery stores in the United States. The FDA has approved its key additive allowing Impossible Foods to move from only selling its products in restaurants and into supermarkets across the country.
-
The FDA is cracking down on a number of companies selling cannabidiol (CBD) products accompanied by unsubstantiated health claims. The latest target is a company called Curaleaf, which sells CBD products claimed to treat everything from cancer and Alzheimer’s, to anxiety and inflammation in dogs.
-
A novel experimental drug is showing promising results from its final phase of human clinical trials. Part of a new class of drugs called JAK-inhibitors, this therapy targets rheumatoid arthritis sufferers and is hoped to be approved for use by the FDA within the next 12 months.
-
The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.